To give you an idea, know that the FDA recommends semaglutide (Wegovy) for weight loss if you meet one of the following criteria: Your BMI is 30 or higher (classified as obesity) Your BMI is 27 or higher (overweight) You have at least one weight-related condition, such as high blood pressure, type 2 diabetes, and high cholesterol Now, you should not take semaglutide if you have: A history of medullary thyroid cancer Multiple endocrine neoplasia syndrome type 2 (MEN2) A history of pancreatitis Gallbladder disease If youre considering semaglutide for weight loss, the first step is to consult your primary care physician or visit a weight loss clinic
Patients on such combinations may require dose reductions of the concomitant insulin or sulfonylurea
Townsend M, Pareja K, Buchanan-Hughes A, Worthington E, Pritchett D, Brubaker M, Houle C, Mose TN, Waters H (2022) Antipsychotic-related stigma and the impact on treatment choices: a systematic review and framework synthesis
Plasma concentrations of alanine transaminase (ALT), aspartate aminotransferase (AST), cholesterol, and C-reactive protein (CRP) were run automated on the Siemens Dimension EXL analyser
Patients on GLP-1 medications often have compromised healing for multiple reasons: nutritional deficiency, dry mouth affecting tissue health, possible acid damage to surrounding areas, and in some cases the metabolic issues that led them to need these medications in the first place
The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research
